The Releef Initiative is a non-profit pharmaceutical corporation. The basic approach of the organization is to operate as a “concept generator”, to develop new applications of old technology and leverage know-how and intellectual property in collaborations with for-profit companies. The organization is managed as a global network with representatives in US, Sweden and Russia. The corporate headquarter is in Los Angeles, California.